COVID-19 in children with neuromuscular disorders.

Daniel Natera-de BenitoSergio Aguilera-AlbesaLaura Costa-ComellasMar García-RomeroMaría Concepción Miranda-HerreroJúlia Rúbies OlivesÓscar García-CamposElena Martínez Del ValMaria Josefa Martinez GarciaInmaculada Medina MartínezRamón Cancho-CandelaMiguel A Fernandez-GarciaSamuel Ignacio Pascual-PascualDavid Gómez-AndrésAndres Nascimentonull null

Published in: Journal of neurology (2021)

The course of COVID-19 in children with neuromuscular disorders may not be as severe as expected. The protective role of young age seems to outweigh the risk factors that are common in neuromuscular patients, such as a decreased respiratory capacity or a weak cough. Further studies are needed to know if this finding can be generalized to children with other chronic diseases.

Keyphrases

coronavirus disease
young adults
sars cov
risk factors
end stage renal disease
chronic kidney disease
newly diagnosed
prognostic factors
early onset
patient reported outcomes
drug induced
respiratory tract